The DPP-4 inhibitors are incretin-related drugs that improve hyperglycemia in a glucose-dependent manner and have been reported to exert favorable effects on atherosclerosis. However, it has not been fully elucidated whether DPP-4 inhibitors are able to improve endothelial function in patients with type 2 diabetes. Therefore, we investigated the efficacy of sitagliptin, a DPP-4 inhibitor, on endothelial function and glycemic metabolism compared with that of the sulfonylurea glimepiride.In this multicenter, prospective, randomized parallel-group comparison study, 103 outpatients with type 2 diabetes (aged 59.9 ± 9.9 years with HbA1c levels of 7.5 ± 0.4%) with dietary cure only and/or current metformin treatment were enrolled and randomly ass...
Background: Experimental studies have suggested that dipeptidyl peptidase-4 (DPP-4) inhibitors provi...
Incretin-related drugs, such as dipeptidyl peptidase-4 (DPP-4) inhibitors and glucagon-like peptide-...
Objectives GLP-1 improves hyperglycemia, and it has been reported to have favorable effects on ath-e...
Objectives; The DPP-4 inhibitors are incretin-related drugs that improve hyperglycemia in a glucose-...
The DPP-4 inhibitors are incretin-related drugs that improve hyperglycemia in a glucose-dependent ma...
DPP-4 inhibitors have been used to treat patients with type 2 diabetes mellitus. These agents not on...
GLP-1 improves hyperglycemia, and it has been reported to have favorable effects on atherosclerosis....
GLP-1 improves hyperglycemia, and it has been reported to have favorable effects on atherosclerosis....
AIM: To assess the efficacy and safety of a 24-week treatment with sitagliptin, a highly selective o...
The aim of this study was to evaluate the effect of gemigliptin vs sitagliptin or glimepiride as ini...
Abstract Background Dipeptidyl peptidase-4 (DPP-4) inhibitors may have protective effects in the ear...
Abstract Background Studies of...
Background-—Endothelial dysfunction is an independent predictor for cardiovascular events in patient...
Dipeptidyl peptidase-4 (DPP-4) inhibitors (gliptins) are oral incretin-based glucose-lowering agents...
Study Aim: We conducted this study to make comparison of anti-inflammatory effects of glimepiride an...
Background: Experimental studies have suggested that dipeptidyl peptidase-4 (DPP-4) inhibitors provi...
Incretin-related drugs, such as dipeptidyl peptidase-4 (DPP-4) inhibitors and glucagon-like peptide-...
Objectives GLP-1 improves hyperglycemia, and it has been reported to have favorable effects on ath-e...
Objectives; The DPP-4 inhibitors are incretin-related drugs that improve hyperglycemia in a glucose-...
The DPP-4 inhibitors are incretin-related drugs that improve hyperglycemia in a glucose-dependent ma...
DPP-4 inhibitors have been used to treat patients with type 2 diabetes mellitus. These agents not on...
GLP-1 improves hyperglycemia, and it has been reported to have favorable effects on atherosclerosis....
GLP-1 improves hyperglycemia, and it has been reported to have favorable effects on atherosclerosis....
AIM: To assess the efficacy and safety of a 24-week treatment with sitagliptin, a highly selective o...
The aim of this study was to evaluate the effect of gemigliptin vs sitagliptin or glimepiride as ini...
Abstract Background Dipeptidyl peptidase-4 (DPP-4) inhibitors may have protective effects in the ear...
Abstract Background Studies of...
Background-—Endothelial dysfunction is an independent predictor for cardiovascular events in patient...
Dipeptidyl peptidase-4 (DPP-4) inhibitors (gliptins) are oral incretin-based glucose-lowering agents...
Study Aim: We conducted this study to make comparison of anti-inflammatory effects of glimepiride an...
Background: Experimental studies have suggested that dipeptidyl peptidase-4 (DPP-4) inhibitors provi...
Incretin-related drugs, such as dipeptidyl peptidase-4 (DPP-4) inhibitors and glucagon-like peptide-...
Objectives GLP-1 improves hyperglycemia, and it has been reported to have favorable effects on ath-e...